Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FEVERALL 325 MG SUPPOSITORY

Acetaminophen
$0.6986per EA
High Outlier
OTC

Strength

325 mg/1

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

51672211604

Classification

Brand

Dosage Form

SUPPOSITORY

Route

RECTAL

Last Updated

7/17/2024

Active Ingredients

ACETAMINOPHEN

Approval Type

New Drug (NDA)

FDA Application

NDA018337

On Market Since

12/12/2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+1.8%

5Y

+0.8%

All

-11.6%

Generic Alternatives

Save up to 97%

9 alternatives • Same active ingredient

QC PAIN RELIEF 325 MG TABLET
Generic
63868008210•Chain Drug Marketing Association
$0.0232
Save 97%
ACETAMINOPHEN 325 MG GELCAP
Generic
46122043078•AmerisourceBergen
$0.0260
Save 96%
ACETAMINOPHEN 325 MG TABLET
Generic
00536132701•Rugby Laboratories
$0.0260
Save 96%
FT PAIN RELIEF 325 MG TABLET
Generic
70677111901•Strategic Sourcing Services LLC
$0.0260
Save 96%
GS PAIN RELIEF 325 MG TABLET
Generic
00113040378•L. Perrigo Company
$0.0260
Save 96%
ACETAMINOPHEN 325 MG TABLET
Generic
00904677361•Major Pharmaceuticals
$0.0260
Save 96%
ACETAMINOPHEN 325 MG TABLET
Generic
68599467909•McKesson
$0.0260
Save 96%
ACETAMINOPHEN 325 MG TABLET
Generic
70000009201•Cardinal Health
$0.0261
Save 96%
FEVERALL 325 MG SUPPOSITORY
Brand
51672211602•Sun Pharmaceutical Industries Inc.
$0.9757
+40% more

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy